Trial intelligence / Profile preview

Estradiol in Hormone Receptor Positive Metastatic Breast Cancer

NCT00324259Phase 2Completed

Sponsor
Washington University School of Medicine
Start
Aug 2004
Primary completion
Mar 2011
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 2 trial of estradiol in breast cancer, sponsored by Washington University School of Medicine. Started Aug 2004; status: completed.

02

Drugs

estradiol
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT00324259.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00324259.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call